← Open Payments lookup

ROBERT NORDMAN: Open Payments

NPI 1891783338 · AUBURN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,097 in 43 payments from 12 companies in 2025. Trend: 2023 $2,178 · 2024 $876 · 2025 $1,097

Food & beverage: $1,097
CompanyPaymentsAmount
Alkermes, Inc.8$238
Teva Pharmaceuticals USA, Inc.6$163
Neurocrine BioSciences, Inc.7$159
Otsuka America Pharmaceutical, Inc.4$114
Almatica Pharma LLC4$84
Axsome Therapeutics, Inc.3$83
E.R. Squibb & Sons, L.L.C.3$69
Takeda Pharmaceuticals U.S.A., Inc.3$59
Sage Therapeutics, LLC2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$33

Products named: ARISTADA, AUSTEDO XR, INGREZZA, REXULTI, LOREEV XR, Auvelity, COBENFY, TRINTELLIX.

Industry payments across CA — which companies pay providers there.